149 related articles for article (PubMed ID: 34991620)
21. High FOXA1 immunohistochemical expression level associates with mucinous histology, favorable clinico-pathological prognostic parameters and survival advantage in epithelial ovarian cancer.
Sheta H; Abd El Hafez A; Saif M; Elsergany AR; Al Emam D; Abdelrazik MM
Pathologica; 2021 Apr; 113(2):102-114. PubMed ID: 34042091
[TBL] [Abstract][Full Text] [Related]
22. Circular RNA ABCB10 promotes cell proliferation and invasion, but inhibits apoptosis via regulating the microRNA‑1271‑mediated Capn4/Wnt/β‑catenin signaling pathway in epithelial ovarian cancer.
Lin X; Chen Y; Ye X; Xia X
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760208
[TBL] [Abstract][Full Text] [Related]
23. HDAC3-Mediated Repression of LncRNA-LET Regulates Gastric Cancer Cell Growth Proliferation, Invasion, Migration, and Apoptosis via MiR-548k.
Zhang J; Liu X; Chen J; Xia S
J Environ Pathol Toxicol Oncol; 2021; 40(4):21-32. PubMed ID: 34936297
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA‑195 suppresses cell proliferation, migration and invasion in epithelial ovarian carcinoma via inhibition of the CDC42/CCND1 pathway.
Hao X; Jia Q; Yuan J; Shi X; Guo H; Gao J; Guo Y
Int J Mol Med; 2020 Nov; 46(5):1862-1872. PubMed ID: 32901852
[TBL] [Abstract][Full Text] [Related]
25. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
26. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
27. HDAC3 deteriorates colorectal cancer progression via microRNA-296-3p/TGIF1/TGFβ axis.
Li J; Hu M; Liu N; Li H; Yu Z; Yan Q; Zhou M; Wang Y; Song Y; Pan G; Liang F; Chen R
J Exp Clin Cancer Res; 2020 Nov; 39(1):248. PubMed ID: 33203425
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1.
Tong Z; Meng X; Wang J; Wang L
Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of FOXA1 inhibits cell proliferation and EMT of human gastric cancer AGS cells.
Lin M; Pan J; Chen Q; Xu Z; Lin X; Shi C
Gene; 2018 Feb; 642():145-151. PubMed ID: 29129808
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
31. Expression of FOXA1 gene regulates the proliferation and invasion of human gastric cancer cells.
Dai Y; Yang G; Yang L; Jiang L; Zheng G; Pan S; Zhu C
Cell Mol Biol (Noisy-le-grand); 2021 Aug; 67(2):161-165. PubMed ID: 34817322
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143
[TBL] [Abstract][Full Text] [Related]
33. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
[TBL] [Abstract][Full Text] [Related]
34. miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1.
Shen SQ; Huang LS; Xiao XL; Zhu XF; Xiong DD; Cao XM; Wei KL; Chen G; Feng ZB
Oncol Rep; 2017 Jul; 38(1):368-376. PubMed ID: 28534958
[TBL] [Abstract][Full Text] [Related]
35. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.
Yoshioka S; King ML; Ran S; Okuda H; MacLean JA; McAsey ME; Sugino N; Brard L; Watabe K; Hayashi K
Mol Cancer Res; 2012 Mar; 10(3):469-82. PubMed ID: 22232518
[TBL] [Abstract][Full Text] [Related]
36. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
37. LncRNA SNHG8 induces ovarian carcinoma cells cellular process and stemness through Wnt/β-catenin pathway.
Miao W; Lu T; Liu X; Yin W; Zhang H
Cancer Biomark; 2020; 28(4):459-471. PubMed ID: 32538821
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
39. SFRP1 inhibited the epithelial ovarian cancer through inhibiting Wnt/β-catenin signaling.
Zhang H; Sun D; Qiu J; Yao L
Acta Biochim Pol; 2019 Nov; 66(4):393-400. PubMed ID: 31770484
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
